SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma informs about board meeting

25 Jan 2017 Evaluate

Marksans Pharma has informed that the meeting of the Board of Directors of the Company will be held on February 06, 2017, to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Third Quarter ended on December 31, 2016 (Q3). Further, as per the Insider Trading Policy of the Company, Trading Window for dealing in Company’s shares will remain closed for the Company’s Insiders from January 25, 2017 (commencing from the time of above intimation to the Stock Exchanges) till 48 hours after the announcement of the third quarter financial results on February 06, 2017.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

178.65 3.60 (2.06%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×